Having observed this industry for nearly 20 years, it is rare to find a market that has fluctuated as dramatically as Cambridge.

The vacancy rate for life sciences research space in the Boston metro area, including Cambridge, reached a record high of 28% as of Q4 2025. According to real estate services firm CBRE, the available lab and life sciences space totals approximately 17 million square feet, and when including sublease space, the overall availability rises to 29.7%. The rapid increase in lab supply during the pandemic is now experiencing a correction as demand slows.

However, there are clear differences within the market. Takeda Pharmaceutical is subleasing about 450,000 square feet of space in early 2026 while simultaneously deciding to lease approximately 600,000 square feet at One Cambridge, 585 Third St., to consolidate its research and development functions. The biotech startup Lila secured one of the largest contracts of the year by leasing 235,500 square feet of lab space in Cambridge in 2025. New ventures are also being attracted, particularly around Kendall Square's AI and biotech convergence cluster and LabCentral's AI biohub.

On the employment front, there are concerns being raised. Industry insiders are voicing worries about a so-called white-collar recession, where highly skilled life sciences professionals are struggling to find their next job, and there are concerns that if Kendall Square operates with significantly fewer staff than before, nearby restaurants, retail, and housing markets could be adversely affected.

Nevertheless, Cambridge's fundamental assets—world-class research institutions like MIT and Harvard, a decades-long accumulated venture capital network, and an early-stage biotech startup ecosystem—provide a structural advantage that is difficult to replicate in a short time elsewhere. In fact, major pharmaceutical companies are also using this period to reorganize and strengthen their presence in Cambridge.

For Korean households, Cambridge remains a top destination for life sciences and research talent in the U.S., but it is important to recognize that we are currently in a transitional phase with rising lab vacancy rates and employment adjustments occurring simultaneously. If considering commercial real estate or related rental investments, it is advisable to exercise caution and wait for the completion of medium- to long-term restructuring rather than expecting a short-term recovery. Residential real estate is considered relatively resilient due to the stable demand from universities and research institutions.

While Cambridge is currently going through a correction period with rising lab vacancy rates, considering the research ecosystem centered around MIT and Harvard and the accumulated capital, it is assessed as a region likely to return to a growth trajectory over the long term of ten years.